Glucosamine, a naturally occurring amino monosaccharide, inhibits A549 and H446 cell proliferation by blocking G1/S transition

Ju,Yinghua; Yu,Aiming; Sun,Xiuhua; Wu,Didi; Zhang,Hongkai

doi:10.3892/mmr.2013.1584

Glucosamine, a naturally occurring amino monosaccharide, inhibits A549 and H446 cell proliferation by blocking G1/S transition

Authors:
- Yinghua Ju
- Aiming Yu
- Xiuhua Sun
- Didi Wu
- Hongkai Zhang
View Affiliations

Affiliations: Department of Biochemistry and Molecular Biology, College of Basic Medical Sciences, China Medical University, Shenyang, Liaoning 110001, P.R. China
Published online on: July 11, 2013 https://doi.org/10.3892/mmr.2013.1584
Pages: 794-798

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Uncontrolled proliferation is important in tumorigenesis. In the present study, the effects of glucosamine on lung cancer cell proliferation were investigated. The expression of cyclin E, one of the key cyclins in the G1/S transition, and Skp2, the ubiquitin ligase subunit that targets the negative cell cycle regulator, p27Kip1, were also assessed. Moreover, the underlying mechanisms of action of glucosamine were investigated in lung cancer cells. A549 and H446 cells were synchronized using thymidine in the presence or absence of glucosamine. The effect of glucosamine on lung cancer cell proliferation was determined by MTT assay. Cyclin E and p27Kip1 proteins and their phosphorylation levels were detected by western blot analysis. Furthermore, the effect of glucosamine on the cell cycle was evaluated by flow cytometry. Glucosamine was found to inhibit lung cancer cell proliferation and to suppress Skp2 and cyclin E expression. Notably, the phosphorylation levels of cyclin E (Thr62) and p27Kip1 (Thr187) were downregulated by glucosamine, and negatively correlated with degradation. Glucosamine was also found to arrest lung cancer cells in the G1/S phase. Thus, glucosamine may inhibit lung cancer cell proliferation by blocking G1/S transition through the inhibition of cyclin E and Skp2 protein expression.

View Figures

View References

1	Crolle G and D’Este E: Glucosamine sulphate for the management of arthrosis: a controlled clinical investigation. Curr Med Res Opin. 7:104–109. 1980. View Article : Google Scholar : PubMed/NCBI
2	Meininger CJ, Kelly KA, Li H, Haynes TE and Wu G: Glucosamine inhibits inducible nitric oxide synthesis. Biochem Biophys Res Commun. 279:234–239. 2000. View Article : Google Scholar : PubMed/NCBI
3	Hua J, Sakamoto K and Nagaoka I: Inhibitory actions of glucosamine, a therapeutic agent for osteoarthritis, on the functions of neutrophils. J Leukoc Biol. 71:632–640. 2002.PubMed/NCBI
4	Ju Y, Hua J, Sakamoto K, Ogawa H and Nagaoka I: Glucosamine, a naturally occurring amino monosaccharide modulates LL-37-induced endothelial cell activation. Int J Mol Med. 22:657–662. 2008.PubMed/NCBI
5	Ju Y, Hua J, Sakamoto K, Ogawa H and Nagaoka I: Modulation of TNF-α-induced endothelial cell activation by glucosamine, a naturally occurring amino monosaccharide. Int J Mol Med. 22:809–815. 2008.
6	Brasky TM, Lampe JW, Slatore CG and White E: Use of glucosamine and chondroitin and lung cancer risk in the VITamins And Lifestyle (VITAL) cohort. Cancer Causes Control. 22:1333–1342. 2011. View Article : Google Scholar : PubMed/NCBI
7	Hwang MS and Baek WK: Glucosamine induces autophagic cell death through the stimulation of ER stress in human glioma cancer cells. Biochem Biophys Res Commun. 399:111–116. 2010. View Article : Google Scholar : PubMed/NCBI
8	Wang Z, Liang R, Huang GS, Piao Y, Zhang YQ, Wang AQ, Dong BX, Feng JL, Yang GR and Guo Y: Glucosamine sulfate-induced apoptosis in chronic myelogenous leukemia K562 cells is associated with translocation of cathepsin D and downregulation of Bcl-xL. Apoptosis. 11:1851–1860. 2006. View Article : Google Scholar : PubMed/NCBI
9	Oh HJ, Lee JS, Song DK, Shin DH, Jang BC, Suh SI, Park JW, Suh MH and Baek WK: D-glucosamine inhibits proliferation of human cancer cells through inhibition of p70S6K. Biochem Biophis Res Commun. 360:840–845. 2007. View Article : Google Scholar : PubMed/NCBI
10	Welcker M and Clurman BE: FBW7 ubiquitin ligase: a tumour suppressor at the crossroads of cell division, growth and differentiation. Nat Rev Cancer. 8:83–93. 2008. View Article : Google Scholar : PubMed/NCBI
11	Nam EJ and Kim YT: Alteration of cell-cycle regulation in epithelial ovarian cancer. Int J Gynecol Cancer. 18:1169–1182. 2008. View Article : Google Scholar : PubMed/NCBI
12	Tammali R, Saxena A, Srivastava SK and Ramana KV: Aldose reductase regulates vascular smooth muscle cell proliferation by modulating G1/S phase transition of cell cycle. Endocrinology. 151:2140–2150. 2010. View Article : Google Scholar : PubMed/NCBI
13	Mittendorf EA, Liu Y, Tucker SL, McKenzie T, Qiao N, Akli S, Biernacka A, Liu Y, Meijer L, Keyomarsi K and Hunt KK: A novel interaction between HER2/neu and cyclin E in breast cancer. Oncogene. 29:3896–3907. 2010. View Article : Google Scholar : PubMed/NCBI
14	Kapur P, Lotan Y, King E, Kabbani W, Mitra AP, Mosbah A, Abol-Enein H, Ghoneim M and Youssef RF: Primary adenocarcinoma of the urinary bladder: value of cell cycle biomarkers. Am J Clin Pathol. 135:822–830. 2011. View Article : Google Scholar : PubMed/NCBI
15	Hsieh HY, Shieh JJ, Chen CJ, Pan MY, Yang SY, Lin SC, Chang JS, Lee AY and Chang CC: Prodigiosin down-regulates SKP2 to induce p27(KIP1) stabilization and antiproliferation in human lung adenocarcinoma cells. Br J Pharmacol. 166:2095–2108. 2012. View Article : Google Scholar : PubMed/NCBI
16	Wang G, Chan CH, Gao Y and Lin HK: Novel roles of Skp2 E3 ligase in cellular senescence, cancer progression, and metastasis. Chin J Cancer. 31:169–177. 2012. View Article : Google Scholar : PubMed/NCBI
17	Lunn CL, Chrivia JC and Baldassare JJ: Activation of Cdk2/Cyclin E complexes is dependent on the origin of replication licensing factor Cdc6 in mammalian cells. Cell Cycle. 9:4533–4541. 2010. View Article : Google Scholar : PubMed/NCBI
18	Wei Z, Jiang X, Liu F, Qiao H, Zhou B, Zhai B, Zhang L, Zhang X, Han L, Jiang H, Krissansen GW and Sun X: Downregulation of Skp2 inhibits the growth and metastasis of gastric cancer cells in vitro and in vivo. Tumour Biol. 34:181–192. 2013. View Article : Google Scholar : PubMed/NCBI
19	Shin E, Kim SH, Jeong HY, Jang JJ and Lee K: Nuclear expression of S-phase kinase-associated protein 2 predicts poor prognosis of hepatocellular carcinoma. APMIS. 120:349–357. 2012. View Article : Google Scholar : PubMed/NCBI
20	Guinez C, Filhoulaud G, Rayah-Benhamed F, Marmier S, Dubuquoy C, Dentin R, Moldes M, Burnol AF, Yang X, Lefebvre T, Girard J and Postic C: O-GlcNAcylation increases ChREBP protein content and transcriptional activity in the liver. Diabetes. 60:1399–1413. 2011. View Article : Google Scholar
21	Carrillo LD, Froemming JA and Mahal LK: Targeted in vivo O-GlcNAc sensors reveal discrete compartment-specific dynamics during signal transduction. J Biol Chem. 286:6650–6658. 2011.PubMed/NCBI
22	Butt AM, Khan IB, Hussain M, Idress M, Lu J and Tong Y: Role of post translational modifications and novel crosstalk between phosphorylation and O-beta-GlcNAc modifications in human claudin-1, -3 and -4. Mol Biol Rep. 39:1359–1369. 2012. View Article : Google Scholar : PubMed/NCBI
23	Schülein C, Eilers M and Popov N: PI3K-dependent phosphorylation of Fbw7 modulates substrate degradation and activity. FEBS Lett. 585:2151–2157. 2011.PubMed/NCBI
24	Lerner M, Lundgren J, Akhoondi S, Jahn A, Ng HF, Akbari Moqadam FA, Oude Vrielink JA, Agami R, Den Boer ML, Grandér D and Sangfelt O: MiRNA-27a controls FBW7/hCDC4-dependent cyclin E degradation and cell cycle progression. Cell Cycle. 10:2172–2183. 2011. View Article : Google Scholar : PubMed/NCBI
25	Brandt Y, Mitchell T, Wu Y and Hartley RS: Developmental downregulation of Xenopus cyclin E is phosphorylation and nuclear import dependent and is mediated by ubiquitination. Dev Biol. 355:65–76. 2011.
26	Yang WH, Kim JE, Nam HW, Ju JW, Kim HS, Kim YS and Cho JW: Modification of p53 with O-linked N-acetylglucosamine regulates p53 activity and stability. Nat Cell Biol. 8:1074–1083. 2006.
27	Smet-Nocca C, Broncel M, Wieruszeski JM, Tokarski C, Hanoulle X, Leroy A, Landrieu I, Rolando C, Lippens G and Hackenberger CP: Identification of O-GlcNAc sites within peptides of the Tau protein and their impact on phosphorylation. Mol Biosyst. 7:1420–1429. 2011.
28	Mishra S, Ande SR and Salter NW: O-GlcNAc modification: why so intimately associated with phosphorylation? Cell Commun Signal. 9:12011. View Article : Google Scholar